HLA-DRB1 and myeloid sarcoma: The study concluded that ETS exposure was 37% more common in MS, in comparison to monophasic acquired demyelinating syndromes (29.5%); however, it was not an independent factor. When associated with the presence of HLADRB1*15, an OR of 3.7 for MS was reached.